Bio :

Dr. Abdelmadjid Hihi is Deputy Director for clinical innovation at DTIS, CEA-Leti’s innovative health technologies division. He is a member of CEA-Leti’s Internal Scientific Council, and is responsible for coordinating international public-private partnerships funded by the European Commission and DARPA in particular for medical devices, biomedical research, and neurotechnologies. Before joining Leti, Madjid was at Génome Québec as Scientific Program Manager; and at Chronogen Inc. (Montreal, Quebec) as R&D group leader. Madjid holds a Ph.D in biological sciences from Lausanne University (1999). He is a former Swiss National Fund postdoctoral fellow, and a McGill University postgraduate alumni.

Abstract :

Integrated medical device development platforms are a must to facilitate the connection between technology R&D and clinical deployment of innovative medical devices. In addition to clinical operability, such platforms may ensure an early compliance to industrial norms and regulatory constraints. These elements are key to successfully bring novel medical devices to the real world. Examples will be discussed based on Leti's cuting-edge research with a focus on brain-computer interfaces to compensate motor handicap, as well as on non-pharmacological therapies for neurodegenerative diseases based on photobiomodulation.